Long-Term Safety of Systemic Ozone Therapy in a Patient With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS)

A patient with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome, a rare mitochondrial disease characterized by myopathy, epilepsy, encephalopathy, acidosis, and recurrent cerebral ischemic episodes, underwent systemic hematogenous ozone therapy for 17 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Romanello, Daniele, Rotunno, Sara, Martinelli, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695090/
http://dx.doi.org/10.7759/cureus.48261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695090/
http://dx.doi.org/10.7759/cureus.48261

Ejemplares similares